Valuation: Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 1.04TCr 153.13Cr 133.82Cr 123.71Cr 114.29Cr 215.23Cr 15TCr 219.13Cr 1.48TCr 578.81Cr 7.2TCr 575.18Cr 562.47Cr 25TCr P/E 2026 *
15.4x
P/E 2027 * 12.8x
Enterprise Value 1.04TCr 153.13Cr 133.82Cr 123.71Cr 114.29Cr 215.23Cr 15TCr 219.13Cr 1.48TCr 578.81Cr 7.2TCr 575.18Cr 562.47Cr 25TCr EV / Sales 2026 *
2.4x
EV / Sales 2027 * 2.18x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 day-0.04%
1 week+3.93%
Current month+11.29%
1 month+0.97%
3 months-4.33%
6 months-14.92%
Current year-14.07%
1 week 22.61
Extreme 22.61
24.48
1 month 21.22
Extreme 21.22
24.48
Current year 21.22
Extreme 21.22
29.22
1 year 21.22
Extreme 21.22
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
33.34
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 28/05/2019
Director of Finance/CFO 49 28/12/2023
Corporate Officer/Principal 40 19/08/2021
Director TitleAgeSince
Chairman 64 16/03/2010
Director/Board Member 48 28/05/2019
Director/Board Member 40 14/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-0.04%+3.93%-13.14%-11.18% 153.02Cr
-2.48%-6.72%+44.19%+156.43% 1,05400Cr
-1.52%-5.01%+61.87%+58.79% 62TCr
-1.30%-3.88%+27.81%+79.97% 44TCr
-1.12%-1.45%+27.34%+22.20% 32TCr
-1.73%-2.14%+27.22%+44.70% 28TCr
-1.95%-12.31%+18.32%+19.69% 26TCr
-1.45%-0.44%-27.17%-38.86% 22TCr
-1.44%-3.49%+19.60%+56.20% 19TCr
-1.04%-4.63%+16.01%+68.47% 16TCr
Average -1.32%-1.98%+20.20%+45.64% 35.58TCr
Weighted average by Cap. -1.41%-2.06%+33.42%+77.26%

Financials

2026 *2027 *
Net sales 431.8Cr 64Cr 56Cr 52Cr 48Cr 90Cr 6.12TCr 91Cr 614.21Cr 240.98Cr 3TCr 239.47Cr 234.18Cr 10TCr 475.4Cr 70Cr 61Cr 57Cr 52Cr 99Cr 6.74TCr 100.44Cr 676.23Cr 265.32Cr 3.3TCr 263.65Cr 257.83Cr 11TCr
Net income 67Cr 9.95Cr 8.7Cr 8.04Cr 7.43Cr 14Cr 955.87Cr 14Cr 96Cr 38Cr 468.06Cr 37Cr 37Cr 1.61TCr 74Cr 11Cr 9.61Cr 8.89Cr 8.21Cr 15Cr 1.06TCr 16Cr 105.97Cr 42Cr 517.37Cr 41Cr 40Cr 1.78TCr
Net Debt - -
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
14/26/14 CN¥24.06 -0.04% 88,80,000
13/26/13 CN¥24.07 +3.53% 1,05,94,547
10/26/10 CN¥23.25 -2.31% 77,08,440
09/26/09 CN¥23.80 +2.28% 97,39,200
08/26/08 CN¥23.27 +2.06% 51,55,200
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
24.06CNY
Average target price
36.25CNY
Spread / Average Target
+50.67%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600993 Stock